My sleep schedule, according to mathematics, leaves me 11 hours — so what’s my problem? My current ultra-efficient carers arrive at 9:30 a.m. and usually get me into the wet room 15 minutes later. Maybe 20 if my bottom has been misbehaving. It’s been something of a miscreant ever since…
Read more
Since the early days of the COVID-19 vaccination program, disinformation claiming that the vaccines can induce multiple sclerosis (MS) has swirled around social media. Recently, there’s been a resurgence of this type of post, sparked by a report published on the World Health Organization (WHO) website titled “…
Long-term treatment with vidofludimus calcium (IMU-838) has been tolerated well overall among people with relapsing-remitting MS (RRMS), new data from an extension study show. Findings were presented at the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, in a poster titled “Assessment of Long-Term Safety…
The European Commission has approved Briumvi (ublituximab) for the treatment of adults with relapsing forms of multiple sclerosis (MS) who have active disease, as defined by clinical or imaging features. The approval, which covers all member states in the European Union, as well as Iceland, Norway, and Liechtenstein,…
Columnist John Connor shares a lot of detail about the constant diarrhea he experienced while in rehab after being hospitalized.
Visit the Multiple Sclerosis News Today forums to connect with others in the MS community.
Listen to the latest episode of The Multiple Sclerosis Podcast, hosted by MS columnist Jennifer Powell.
Get regular updates to your inbox.
